Brief: Longboard Pharmaceuticals Says Expects To Report That Cash, Cash Equivalents, Short-Term Investments As Of Dec. 31, 2022 Were About $67.6 Million
07/02/2023 21:52
Feb 7 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* LONGBOARD PHARMACEUTICALS INC - EXPECTS TO REPORT THAT
CASH,
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF DECEMBER 31,
2022 WERE ABOUT $67.6 MILLION
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions